API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
42
PharmaCompass offers a list of Mesalazine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Mesalazine manufacturer or Mesalazine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Mesalazine manufacturer or Mesalazine supplier.
PharmaCompass also assists you with knowing the Mesalazine API Price utilized in the formulation of products. Mesalazine API Price is not always fixed or binding as the Mesalazine Price is obtained through a variety of data sources. The Mesalazine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Apriso manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Apriso, including repackagers and relabelers. The FDA regulates Apriso manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Apriso API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Apriso manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Apriso supplier is an individual or a company that provides Apriso active pharmaceutical ingredient (API) or Apriso finished formulations upon request. The Apriso suppliers may include Apriso API manufacturers, exporters, distributors and traders.
click here to find a list of Apriso suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Apriso DMF (Drug Master File) is a document detailing the whole manufacturing process of Apriso active pharmaceutical ingredient (API) in detail. Different forms of Apriso DMFs exist exist since differing nations have different regulations, such as Apriso USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Apriso DMF submitted to regulatory agencies in the US is known as a USDMF. Apriso USDMF includes data on Apriso's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Apriso USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Apriso suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Apriso Drug Master File in Japan (Apriso JDMF) empowers Apriso API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Apriso JDMF during the approval evaluation for pharmaceutical products. At the time of Apriso JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Apriso suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Apriso Drug Master File in Korea (Apriso KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Apriso. The MFDS reviews the Apriso KDMF as part of the drug registration process and uses the information provided in the Apriso KDMF to evaluate the safety and efficacy of the drug.
After submitting a Apriso KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Apriso API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Apriso suppliers with KDMF on PharmaCompass.
A Apriso CEP of the European Pharmacopoeia monograph is often referred to as a Apriso Certificate of Suitability (COS). The purpose of a Apriso CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Apriso EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Apriso to their clients by showing that a Apriso CEP has been issued for it. The manufacturer submits a Apriso CEP (COS) as part of the market authorization procedure, and it takes on the role of a Apriso CEP holder for the record. Additionally, the data presented in the Apriso CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Apriso DMF.
A Apriso CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Apriso CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Apriso suppliers with CEP (COS) on PharmaCompass.
A Apriso written confirmation (Apriso WC) is an official document issued by a regulatory agency to a Apriso manufacturer, verifying that the manufacturing facility of a Apriso active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Apriso APIs or Apriso finished pharmaceutical products to another nation, regulatory agencies frequently require a Apriso WC (written confirmation) as part of the regulatory process.
click here to find a list of Apriso suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Apriso as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Apriso API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Apriso as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Apriso and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Apriso NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Apriso suppliers with NDC on PharmaCompass.
Apriso Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Apriso GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Apriso GMP manufacturer or Apriso GMP API supplier for your needs.
A Apriso CoA (Certificate of Analysis) is a formal document that attests to Apriso's compliance with Apriso specifications and serves as a tool for batch-level quality control.
Apriso CoA mostly includes findings from lab analyses of a specific batch. For each Apriso CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Apriso may be tested according to a variety of international standards, such as European Pharmacopoeia (Apriso EP), Apriso JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Apriso USP).